Fig. 2From: Loureirin B inhibits the proliferation of hepatic stellate cells and the Wnt/β-catenin signaling pathway by regulating miR-148-3pLoureirin B promotes the apoptosis of HSCs. a Activated hepatic stellate cells (aHSCs) were treated with 50 and 100 ng/μl loureirin B for 48 h, and then assessed using flow cytometry. b Statistical analysis of flow cytometry results. Data are the means ± SEM from four independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001Back to article page